GSK in the news: UK drug pricing tensions and leadership chatter amid NHS debates. Global pharma giant, founded 2000 from Glaxo Wellcome & SmithKline Beecham.
GSK has struck a multi-billion deal to acquire Nuvalent, adding three late-stage cancer drugs to its portfolio, including two lung-cancer therapies under FDA review. The acquisition aims to boost sales growth, expand the lung-cancer platform, and position GSK for a potential rise in annual revenue by 2031.